Chaim Lebovits - Jan 1, 2025 Form 4 Insider Report for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Role: President & CEO
Signature: /s/ Chaim Lebovits
Stock symbol: BCLI
Transactions as of: Jan 1, 2025
Transactions value $: $0
Form type: 4
Date filed: 1/3/2025, 05:36 PM
Previous filing: Oct 2, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BCLI	Common Stock	Award	$0	+120K	+148.22%	$0.00	201K	Jan 1, 2025	Direct	F1
holding	BCLI	Common Stock						133K	Jan 1, 2025	See footnote	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of restricted stock awarded under the Issuer's 2014 Global Share Option Plan. The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
F2	Includes (i) 128,919 shares of Common Stock owned by ACCBT Corp. and (ii) 4,470 shares of Common Stock owned by ACC International Holdings Ltd. Reporting Person may be deemed the beneficial owner of these shares.

Content

Represents shares of restricted stock awarded under the Issuer's 2014 Global Share Option Plan. The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

Includes (i) 128,919 shares of Common Stock owned by ACCBT Corp. and (ii) 4,470 shares of Common Stock owned by ACC International Holdings Ltd. Reporting Person may be deemed the beneficial owner of these shares.